The emerging trend in diabetes care is undoubtedly centered around GLP-1 therapies, and BrightMeds is at the forefront of this wave . These groundbreaking drugs, initially designed for treating type 2 diabetes, are now commonly prescribed – or being explored – for their impressive ability to prom